Tweetable abstract Obstructive sleep apnoea is a risk factor for cardiovascular morbidity and
mortality. There is a need for innovative research strategies evaluating the positive …

Minimally symptomatic OSA is more prevalent than symptomatic disease, and treatment of
this group for cardiovascular risk is contentious. We investigated the effect of six months …

Background Previous, largely uncontrolled studies demonstrated the substantial effects of
continuous positive airway pressure ventilation (CPAP) on a variety of physiologic and …

Abstract The Sleep Apnea cardioVascular Endpoints (SAVE) study is an ongoing
investigator-initiated and conducted, international, multicenter, open, blinded endpoint …

Background Obstructive sleep apnoea (OSA) is a risk factor for hypertension and associated
with increased cardiovascular risk. Continuous positive airway pressure (CPAP) is …

Obstructive sleep apnea (OSA) is associated with increased cardiovascular morbidity and
mortality. Continuous positive airway pressure (CPAP) is the main treatment of OSA. The …

Dyslipidaemia is a well-known risk factor for coronary artery disease (CAD), and reducing
lipid levels is essential for secondary prevention in management of these high-risk …

Sleep-disordered breathing (and obstructive sleep apnea, OSA) is a common pathology in
the general population in economically developed countries. In the last decades, CPAP …

Background A strong association between obstructive sleep apnea (OSA) and the risk for
cardiovascular and cerebrovascular diseases has been reported. Continuous positive …

Background Excessive daytime sleepiness is a frequent symptom of obstructive sleep apnea
(OSA) and has been proposed as a motivator for adherence to continuous positive airway …